Found: 20
Select item for more details and to access through your institution.
O4-03-02: The gamma secretase inhibitor MK-0752 acutely and significantly reduces CSF Abeta40 concentrations in humans
- Published in:
- 2006
- By:
- Publication type:
- Abstract
O4-03-02: The gamma secretase inhibitor MK-0752 acutely and significantly reduces CSF Abeta40 concentrations in humans
- Published in:
- 2006
- By:
- Publication type:
- Abstract
Pharmacokinetic assessment of an oral enalapril suspension for use in children.
- Published in:
- Biopharmaceutics & Drug Disposition, 2000, v. 21, n. 9, p. 339, doi. 10.1002/bdd.241
- By:
- Publication type:
- Article
Effects of the neurokinin<sub>1</sub> receptor antagonist aprepitant on the pharmacokinetics of dexamethasone and methylprednisolone<sup>*</sup>.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 74, n. 1, p. 17, doi. 10.1016/S0009-9236(03)00066-3
- By:
- Publication type:
- Article
The gastrin-receptor antagonist L-365,260 inhibits stimulated acid secretion in humans.
- Published in:
- Clinical Pharmacology & Therapeutics, 1993, v. 54, n. 5, p. 533, doi. 10.1038/clpt.1993.185
- By:
- Publication type:
- Article
Transcutaneous theophylline collection in preterm infants.
- Published in:
- Clinical Pharmacology & Therapeutics, 1990, v. 47, n. 4, p. 427, doi. 10.1038/clpt.1990.53
- By:
- Publication type:
- Article
Characterizing the PK/ PD relationship for inhibition of capsaicin-induced dermal vasodilatation by MK-3207, an oral calcitonin gene related peptide receptor antagonist.
- Published in:
- British Journal of Clinical Pharmacology, 2015, v. 79, n. 5, p. 831, doi. 10.1111/bcp.12547
- By:
- Publication type:
- Article
The potent calcitonin gene-related peptide receptor antagonist, telcagepant, does not affect nitroglycerin-induced vasodilation in healthy men.
- Published in:
- British Journal of Clinical Pharmacology, 2011, v. 71, n. 5, p. 708, doi. 10.1111/j.1365-2125.2010.03869.x
- By:
- Publication type:
- Article
Inhibition of capsaicin-induced increase in dermal blood flow by the oral CGRP receptor antagonist, telcagepant (MK-0974).
- Published in:
- British Journal of Clinical Pharmacology, 2010, v. 69, n. 1, p. 15, doi. 10.1111/j.1365-2125.2009.03543.x
- By:
- Publication type:
- Article
Tolerability, pharmacokinetics and night-time effects on postural sway and critical flicker fusion of gaboxadol and zolpidem in elderly subjects.
- Published in:
- British Journal of Clinical Pharmacology, 2009, v. 67, n. 2, p. 180, doi. 10.1111/j.1365-2125.2008.03331.x
- By:
- Publication type:
- Article
Effect of Aprepitant 40 mg on Cytochrome P-450 2C9 Activity: A Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study in Healthy Young Adults.
- Published in:
- Journal of Applied Research, 2009, v. 9, n. 4, p. 123
- By:
- Publication type:
- Article
Aprepitant when added to a standard antiemetic regimen consisting of ondansetron and dexamethasone does not affect vinorelbine pharmacokinetics in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2007, v. 59, n. 3, p. 407, doi. 10.1007/s00280-006-0359-6
- By:
- Publication type:
- Article
Lack of effect of aprepitant on the pharmacokinetics of docetaxel in cancer patients.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2005, v. 55, n. 6, p. 609, doi. 10.1007/s00280-004-0946-3
- By:
- Publication type:
- Article
Pharmacokinetics of famotidine in infants.
- Published in:
- 2005
- By:
- Publication type:
- journal article
Early-stage comparative effectiveness: Randomized controlled trial with histamine inverse agonist MK-7288 in excessive daytime sleepiness patients.
- Published in:
- Journal of Clinical Pharmacology, 2013, v. 53, n. 12, p. 1294, doi. 10.1002/jcph.182
- By:
- Publication type:
- Article
Single- and Multiple-Dose Pharmacokinetics and Tolerability of Telcagepant, an Oral Calcitonin Gene-Related Peptide Receptor Antagonist, in Adults.
- Published in:
- Journal of Clinical Pharmacology, 2010, v. 50, n. 12, p. 1367, doi. 10.1177/0091270010361741
- By:
- Publication type:
- Article
Lack of Effect of Aprepitant on Hydrodolasetron Pharmacokinetics in CYP2D6 Extensive and Poor Metabolizers.
- Published in:
- Journal of Clinical Pharmacology, 2006, v. 46, n. 7, p. 792, doi. 10.1177/0091270006288954
- By:
- Publication type:
- Article
Lack of Effect of Aprepitant on Digoxin Pharmacokinetics in Healthy Subjects.
- Published in:
- Journal of Clinical Pharmacology, 2003, v. 43, n. 8, p. 912, doi. 10.1177/0091270003256113
- By:
- Publication type:
- Article
Human Pharmacokinetics and Tolerability of L-365,260, a Novel Cholecystokinin-B Antagonist.
- Published in:
- 1996
- By:
- Publication type:
- Other
Effect of Telcagepant on Spontaneous Ischemia in Cardiovascular Patients in a Randomized Study.
- Published in:
- Headache: The Journal of Head & Face Pain, 2011, v. 51, n. 6, p. 954, doi. 10.1111/j.1526-4610.2011.01901.x
- By:
- Publication type:
- Article